FDA’s decision to refuse over-the-counter access of morning-after pill is ‘solid’ and ‘scientific’
Facebook Twitter Google+ Pinterest Addthis

.- A public policy analyst with the Secretariat for Pro-Life Activities of the U.S. Conference of Catholic Bishops is defending the recent decision, made by the Food and Drug Administration, refusing to make the morning-after pill available over-the-counter.

Since the FDA’s decision, pro-abortion groups have accused the government body of having mixed politics with science and of not having based their decision on sufficient scientific evidence. They have called for an investigation into the decision process and pro-abortion members of Congress have also introduced a bill, the Science Over Politics Act. The act would require the FDA commissioner to state, under penalty of perjury, that his decision was not influenced by politics.

However, Maureen Kramlich, a public policy analyst with the USCCB, has argued that the FDA’s decision is on “solid scientific ground” and that it places “the health interests of women, especially young women and girls, above a for-profit drug company’s financial interests.”

The FDA’s concern about the impact that an over-the-counter designation would have on adolescent girls’ health is well founded, she said. 

In an article she wrote, Kramlich cited the experience of a pharmacist in the United Kingdom, where the pills are available without a prescription. The pharmacist reported that a 10-year-old girl, who had requested the pills, said she had already used the morning-after pill four times.

“Other UK pharmacists have reported seeing boyfriends lurking in the back of the store, and have expressed concerns that less assertive women and young girls are being coerced to take the pills,” said Kramlich.

The FDA made its decision based on the insufficient research done on the effects of the drug on adolescents. During an FDA meeting, the manufacturer, Barr Laboratories, admitted that there were no animal studies of the drugs’ effects on adolescents, reported Kranlich.

The FDA also considered that many women are not aware of the drug’s abortifacient properties – it blocks the implantation of an embryo in the womb – and that such information should be printed on the box.

Physicians noted that an over-the-counter designation could be used to exploit young women’s fears of becoming pregnant and that many women would take the drug unnecessarily, even in their times of infertility, said Kramlich. The designation could create a tendency for this drug to be used and sold much more than is really needed.

“One financial news Web site provided estimates that over-the-counter availability of the drugs could bring $25-$100 million in annual revenues for Barr,” wrote Kramlich.

Ads by AdsLiveMedia(What's this?)

* The number of messages that can be online is limited. CNA reserves the right to edit messages for content and tone. Comments and opinions expressed by users do not necessarily reflect the opinions or beliefs of CNA. CNA will not publish comments with abusive language, insults or links to other pages


Ads by Google (What's this?)
Ads by Google

Featured Videos

Little Sisters of the Poor press conference in Denver
Little Sisters of the Poor press conference in Denver
Family thrilled to see Pope Francis in Istanbul
Syrian Refugee, Sara, 14, Before Meeting Pope
Ebola orphans thousands of children in West Africa
One year after Haiyan: Philippines rebuilds homes, lives
An Indian contribution to the Vatican's Synod on the Family
Christ Cathedral CNA video Sept 2014
Alejandro Bermudez of CNA accepts ice bucket challenge
'The Real Albania,' remembering those who fled
Pope Francis in Albania, "one of the most important visits of the post-communist era in Albania"
Pope Francis greets paralyzed man who risked all to see him
Franciscans on the banks of the Tiber in Rome, working for the New Evangelization
Pilgrimage from Czech Republic to Assisi and Rome for intentions
Testimony of young Indian who met Pope in Korea
Preparations of the Closing Mass of 6th Asian Youth Day
Missionary of Charity, Korea
Testimony of Christian Love during Pope's Visit to Korea
Religious Sisters in South Korea react to Pope Francis kissing a baby
Warm atmosphere during Holy Mass at Daejeon World Cup Stadium
Images inside Pope Francis flight to South Korea

Liturgical Calendar

December 19, 2014

Advent Weekday

All readings:
Today »
This year »

Catholic Daily

Gospel of the Day

Mt 21:23-27


Daily Readings

First Reading:: Judg 13: 2-7, 24-25A
Gospel:: Lk 1: 5-25

Saint of the Day

St. Romuald »


Homily of the Day

Mt 21:23-27